Lemaitre Vascular (LMAT) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Wall St futures mixed as Apple falls on margin warning, midterm results awaited
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
First Analysis Downgrades LeMaitre Vascular (LMAT) to Equal Weight Citing Valuation
October 27, 2017 6:09 AM EDTFirst Analysis downgraded LeMaitre Vascular (NASDAQ: LMAT) from Overweight to Equal Weight.
Analyst Tracy Marshbanks cites valuation for the downgrade while reminding clients that the fundamentals continue to look attractive.
For an analyst ratings summary and ratings history on LeMaitre Vascular... More



